Connection
Warren Capell to Hospital Mortality
This is a "connection" page, showing publications Warren Capell has written about Hospital Mortality.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.136 |
|
|
|
-
Capell WH, Barnathan ES, Piazza G, Spyropoulos AC, Hsia J, Bull S, Lipardi C, Sugarmann C, Suh E, Rao JP, Hiatt WR, Bonaca MP. Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. Am Heart J. 2021 05; 235:12-23.
Score: 0.136